First Eagle Investment Management
FLNA

First Eagle Investment Management’s Filana Therapeutics FLNA Stock Holding History

First Eagle Investment Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,695,395
Closed -$2.05M – 136
2019
Q2 		$2.05M Sell
1,695,395
-786
-0% -$891 0.01% 132
2019
Q1 		$2.19M Sell
1,696,181
-24,229
-1% -$27.8K 0.01% 138
2018
Q4 		$1.46M Hold
1,720,410
– – ﹤0.01% 147
2018
Q3 		$1.74M Buy
1,720,410
+784,314
+84% +$1.19M ﹤0.01% 153
2018
Q2 		$1.93M Hold
936,096
– – ﹤0.01% 154
2018
Q1 		$6.64M Hold
936,096
– – 0.02% 133
2017
Q4 		$3.74M Buy
936,096
+1
+0% +$4 0.01% 176
2017
Q3 		$3.81M Sell
936,095
-7,143
-0.8% -$25.5K 0.01% 180
2017
Q2 		$3.89M Buy
943,238
+1
+0% +$5 0.01% 174
2017
Q1 		$5.9M Hold
943,237
– – 0.01% 164
2016
Q4 		$3.77M Hold
943,237
– – 0.01% 178
2016
Q3 		$6.6M Hold
943,237
– – 0.02% 178
2016
Q2 		$14.5M Buy
943,237
+131,164
+16% +$2.08M 0.04% 165
2016
Q1 		$12.7M Hold
812,073
– – 0.03% 161
2015
Q4 		$9.95M Hold
812,073
– – 0.02% 159
2015
Q3 		$10.4M Hold
812,073
– – 0.03% 155
2015
Q2 		$9.83M Hold
812,073
– – 0.02% 163
2015
Q1 		$10.7M Hold
812,073
– – 0.03% 162
2014
Q4 		$11.5M Buy
812,073
+90,525
+13% +$1.57M 0.03% 159
2014
Q3 		$19.7M Buy
721,548
+82,300
+13% +$2.5M 0.05% 154
2014
Q2 		$25.7M Buy
639,248
+115,855
+22% +$4.29M 0.06% 149
2014
Q1 		$20.2M Buy
523,393
+105,195
+25% +$3.71M 0.05% 130
2013
Q4 		$14.2M Buy
418,198
+70,779
+20% +$1.88M 0.04% 138
2013
Q3 		$6.62M Buy
347,419
+81,405
+31% +$1.42M 0.02% 171
2013
Q2 		$4.12M Buy
+266,014
New +$5.62M 0.01% 198

Other funds holding FLNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

First Eagle Investment Management's FLNA Position: Q3 2019 in Review

First Eagle Investment Management sold out of Filana Therapeutics (FLNA) in Q3 2019, closing a stake of 1,695,395 shares — an estimated $2.05M sold.

First Eagle Investment Management first reported a position in FLNA in Q2 2013 and held it in 25 quarters. The position peaked at $25.7M in Q2 2014. 23 funds tracked by Wall St. Rank hold FLNA as of Q3 2019.

  • First Eagle Investment Management reported no remaining Filana Therapeutics position as of Q3 2019 after selling out during the quarter.
  • First Eagle Investment Management sold 1,695,395 Filana Therapeutics shares in Q3 2019, an estimated $2.05M.
  • First Eagle Investment Management first reported a position in Filana Therapeutics in Q2 2013 and held it in 25 quarters.
  • First Eagle Investment Management's Filana Therapeutics position peaked at $25.7M in Q2 2014.
  • 23 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2019.

Based on First Eagle Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.